You searched for "Demodex"
Beyond ‘Shield and Ship’: a novel device (Eye-Aid) to provide temporary aqueous tamponade
The authors present a pilot efficacy study of the novel Eye-Aid device in a porcine model of full-thickness corneal wounds to mitigate anterior chamber collapse in the forward military environment. Currently, the ‘Shield and Ship’ paradigm taught to military healthcare...What's trending Dec/Jan 2025
A round-up of the eye-related hot topics that have been trending on social media over the last few weeks. #ChrisMcCausland #KeepDancing I wrote in my last article about how overjoyed I was to hear Chris McCausland was joining the Strictly...Understanding optical lab processes at 100% Optical
Boosting understanding amongst the entire practice team about what happens in the optical lens manufacturing process was a keynote lecture which drew a packed audience to the OSA stand at 100% Optical.Specsavers joins IAPB to advocate for better eye health
The International Agency for the Prevention of Blindness (IAPB) proudly welcomes Specsavers as a pivotal new member, joining the global alliance for the eye health sector in the fight against avoidable sight loss. "For more than four decades, Specsavers has...
Nerve head in healthy humans using OCT-angiography
Optical coherence tomography angiography (OCT-A) is a recent, dyeless, and noninvasive imaging technique for evaluating depth-resolved vascular status by capturing the dynamic motion of the erythrocytes. It provides the flow map of major vessels and capillary plexuses separately in different...
Aflibercept, bevacizumab or ranibizumab for diabetic macular oedema
Macular oedema (MO) is a leading cause of visual impairment in patients with diabetic retinopathy. Whilst laser photocoagulation therapy has been the proven treatment for decades, studies over the last five years have also established a role for anti-VEGF agents...Haag-Streit UK announces appointment of Thomas Lenzen as new CEO
Haag-Streit UK is pleased to announce the appointment of Thomas Lenzen as the new Chief Executive Officer (CEO) of the Haag-Streit Group. Thomas Lenzen. With more than two decades of international leadership experience in the med tech industry, Thomas Lenzen...
